Hausmann, David http://orcid.org/0000-0002-0571-4710
Hoffmann, Dirk C. http://orcid.org/0000-0003-1370-1933
Venkataramani, Varun http://orcid.org/0000-0002-2927-0886
Jung, Erik
Horschitz, Sandra
Tetzlaff, Svenja K.
Jabali, Ammar
Hai, Ling
Kessler, Tobias http://orcid.org/0000-0001-8350-7074
Azoŕin, Daniel D.
Weil, Sophie
Kourtesakis, Alexandros
Sievers, Philipp http://orcid.org/0000-0003-3237-6021
Habel, Antje http://orcid.org/0000-0003-3472-4165
Breckwoldt, Michael O. http://orcid.org/0000-0002-9980-2390
Karreman, Matthia A.
Ratliff, Miriam http://orcid.org/0000-0002-9464-6544
Messmer, Julia M. http://orcid.org/0000-0001-7858-1501
Yang, Yvonne
Reyhan, Ekin http://orcid.org/0000-0002-2109-0186
Wendler, Susann
Löb, Cathrin
Mayer, Chanté
Figarella, Katherine http://orcid.org/0000-0003-3305-9167
Osswald, Matthias
Solecki, Gergely
Sahm, Felix http://orcid.org/0000-0001-5441-1962
Garaschuk, Olga
Kuner, Thomas
Koch, Philipp http://orcid.org/0000-0003-3713-8786
Schlesner, Matthias http://orcid.org/0000-0002-5896-4086
Wick, Wolfgang http://orcid.org/0000-0002-6171-634X
Winkler, Frank http://orcid.org/0000-0003-4892-6104
Article History
Received: 4 February 2021
Accepted: 3 November 2022
First Online: 14 December 2022
Competing interests
: E.J., M.O., W.W. and F.W. are inventors on patent no. WO2017020982A1 titled ‘Agents for Use in the Treatment of Glioma’. F.W. reports a research collaboration with DC Europa Limited, GlaxoSmithKline, Genentech and Boehringer. F.W. is co-founder of DC Europa Limited. M.R. reports a research grant from Novocure and honoraria, consulting fees and lecture fees from Novocure and Alexxion (now AstraZeneca). G.S. is an employee of Carl Zeiss Microscopy GmbH. F.S. received honoraria from Bayer and Illumina. W.W. is an inventor and patent holder on ‘Peptides for use in Treating or Diagnosing IDH1R132H Positive Cancers’ (patent no. EP2800580B1) and ‘Cancer Therapy with an Oncolytic Virus Combined with a Checkpoint Inhibitor’ (US11027013B2). He has consulted for Apogenix, AstraZeneca, Bayer, Enterome, Medac, MSD and Roche/Genentech, with honoraria paid to the Medical Faculty at the University of Heidelberg.